UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of cancer, ISSN 0020-7136, 06/2007, Volume 120, Issue 12, pp. 2723 - 2733
regulatory T cells | melanoma | peptide vaccination | Regulatory T cells | Peptide vaccination | Melanoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Immunotherapy | Pharmacology. Drug treatments | Tumors | Melanoma - blood | Interleukin-2 - adverse effects | Recombinant Fusion Proteins - adverse effects | Humans | Membrane Glycoproteins - chemistry | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Proteins - immunology | Male | Antineoplastic Agents - therapeutic use | Antigens, Neoplasm - chemistry | Dose-Response Relationship, Drug | gp100 Melanoma Antigen | Diphtheria Toxin - therapeutic use | Flow Cytometry | Vaccination - methods | Melanoma - prevention & control | Time Factors | Antineoplastic Agents - adverse effects | Diphtheria Toxin - adverse effects | T-Lymphocytes - drug effects | Adult | Female | Membrane Glycoproteins - immunology | Dimerization | Interleukin-2 Receptor alpha Subunit - immunology | CD4 Antigens - immunology | Cell Survival - drug effects | Antigens, Neoplasm - immunology | Neoplasm Proteins - chemistry | Treatment Outcome | CD8 Antigens - immunology | Leukapheresis | T-Lymphocytes - cytology | Melanoma - immunology | Eczema - chemically induced | MART-1 Antigen | T-Lymphocytes - immunology | Aged | Cell Proliferation - drug effects | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 03/2013, Volume 119, Issue 5, pp. 978 - 985
hematopoietic stem cell transplantation | mismatched | haploidentical | human leukocyte antigen | allogeneic | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Haplotypes | Follow-Up Studies | Humans | Middle Aged | Leukemia - therapy | Male | Treatment Outcome | Lymphocyte Depletion | Graft vs Host Disease - immunology | Transplantation Chimera | Transplantation, Homologous | Young Adult | Adolescent | Adult | Female | HLA Antigens | Hematopoietic Stem Cell Transplantation - methods | Histocompatibility | Blood Transfusion - methods | Usage | Care and treatment | Patient outcomes | Leukemia | Cellular therapy | Stem cells | Transplantation | Methods | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of experimental medicine, ISSN 0022-1007, 05/2012, Volume 209, Issue 5, pp. 1001 - 1010
Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Encephalomyelitis, Autoimmune, Experimental - physiopathology | Multiple Sclerosis, Relapsing-Remitting - immunology | Specific Pathogen-Free Organisms | Multiple Sclerosis, Relapsing-Remitting - therapy | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Rituximab | DNA Primers - genetics | Adoptive Transfer | Interleukin-6 - deficiency | Reverse Transcriptase Polymerase Chain Reaction | Interleukin-6 - secretion | B-Lymphocytes - drug effects | Encephalomyelitis, Autoimmune, Experimental - therapy | Animals | B-Lymphocytes - immunology | B-Lymphocytes - secretion | Flow Cytometry | Analysis of Variance | Statistics, Nonparametric | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | Lymphocyte Depletion - methods | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 07/2007, Volume 21, Issue 7, pp. 1387 - 1394
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Antilymphocyte Serum - therapeutic use | Hematopoietic Stem Cell Transplantation - methods | T-Lymphocytes | Lymphocyte Depletion - methods | Humans | Immunologic Factors - therapeutic use | Prevention | Usage | Stem cells | Transplantation | T cell proliferation | Research | Pharmacokinetics | Antithymocyte globulin | Health aspects | Methods | Graft rejection | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2008, Volume 358, Issue 7, pp. 676 - 688
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Gadolinium | Male | Immunoglobulins - blood | Adult | Female | B-Lymphocytes - metabolism | Multiple Sclerosis, Relapsing-Remitting - pathology | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Antibodies, Monoclonal - pharmacology | Rituximab | Remission Induction | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Adolescent | Brain - pathology | Immunologic Factors - adverse effects | Infusions, Intravenous | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Causes of | B cells | Drug therapy | Health aspects | Sclerosis | Disability | Multiple sclerosis | Cytokines | Lymphocytes | Patients | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 12, pp. 2709 - 2720
Life Sciences & Biomedicine | Hematology | Science & Technology | Immunohistochemistry | Immunotherapy, Adoptive - adverse effects | Recombinant Fusion Proteins - immunology | Immunotherapy, Adoptive - methods | Transduction, Genetic | Enzyme-Linked Immunosorbent Assay | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Remission Induction | T-Lymphocytes - transplantation | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | B-Lymphocytes - immunology | Flow Cytometry | Lymphoma, B-Cell - immunology | T-Lymphocytes - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Real-Time Polymerase Chain Reaction | Antigens, CD19 - immunology | Cytokines - adverse effects | Cytokines - immunology | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia | Clinical Trials and Observations | Plenary Paper | Gene Therapy
Journal Article
Diabetes care, ISSN 0149-5992, 02/2014, Volume 37, Issue 2, pp. 453 - 459
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Area Under Curve | Humans | Rituximab | Male | Diabetes Mellitus, Type 1 - therapy | Young Adult | B-Lymphocytes - immunology | Adolescent | Islets of Langerhans - physiopathology | Placebos | Adult | Female | Child | Lymphocyte Depletion - methods | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Emerging Technologies and Therapeutics
Journal Article
Science translational medicine, ISSN 1946-6234, 08/2016, Volume 8, Issue 352, pp. 352ra110 - 352ra110
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Immunotherapy - methods | Cytokines - metabolism | Lymphocyte Activation | Humans | Mice, Inbred C57BL | Translational Medical Research | Neoplasms, Experimental - therapy | Antigen-Presenting Cells - immunology | Mice, Knockout | T-Lymphocytes, Regulatory - immunology | Phototherapy - methods | Animals | Interleukin-2 Receptor alpha Subunit - metabolism | Neoplasms, Experimental - immunology | Cell Line, Tumor | Killer Cells, Natural - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Lymphocyte Depletion - methods | Interferon-gamma - biosynthesis | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 03/2016, Volume 172, Issue 5, pp. 667 - 684
veto cell | graft‐versus host disease | graft anti‐tumour | nonmyeloablative/reduced conditioning | anti‐third‐party CD8+ Tcm | Veto cell | Anti-third-party CD8 | Graft anti-tumour | Graft-versus host disease | Tcm | Nonmyeloablative/reduced conditioning | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematopoietic Stem Cell Transplantation - trends | Immunotherapy, Adoptive - methods | Humans | Hematopoietic Stem Cell Transplantation - adverse effects | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Graft Rejection - immunology | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Graft vs Host Disease - immunology | Lymphocyte Depletion - methods | Transplantation | T cells | Analysis | Stem cells | Index Medicus
Journal Article